ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Vetoquinol

Vetoquinol (VETO)

79.30
1.00
(1.28%)
Closed November 24 11:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
79.30
Bid
79.30
Ask
79.80
Volume
1,140
78.40 Day's Range 80.30
77.90 52 Week Range 110.00
Market Cap
Previous Close
78.30
Open
78.40
Last Trade
1
@
79.3
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
2,523
Shares Outstanding
11,834,162
Dividend Yield
1.07%
PE Ratio
16.89
Earnings Per Share (EPS)
4.69
Revenue
542.01M
Net Profit
55.56M

About Vetoquinol

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Lure, Fra
Founded
-
Vetoquinol is listed in the Pharmaceutical Preparations sector of the Euronext with ticker VETO. The last closing price for Vetoquinol was 78.30 €. Over the last year, Vetoquinol shares have traded in a share price range of 77.90 € to 110.00 €.

Vetoquinol currently has 11,834,162 shares outstanding. The market capitalization of Vetoquinol is 926.61 € million. Vetoquinol has a price to earnings ratio (PE ratio) of 16.89.

VETO Latest News

Vetoquinol: Sales at End September 2024

9-month sales: €398 million (+1.8% at constant exchange rates and +1.6% on a reported basis) 9-month sales of essential products: €241million (+3.9% at constant exchange rates and on a reported...

VETOQUINOL : RÉSULTATS 1ER SEMESTRE 2024

Chiffre d’affaires : 264 M€ (+3,2 % à données publiées) CA produits Essentiels : 160 M€ (+6,0 % à données publiées) Résultat net part du Groupe : 24 M€ (9,0 % du CA) EBITDA : 45 M€ (17,0 % du...

VETOQUINOL : CHIFFRE D’AFFAIRES 1ER TRIMESTRE 2024 : 134 M€

Regulatory News: Matthieu Frechin, Président-directeur général du laboratoire Vetoquinol (Paris:VETO), a déclaré : « Les bonnes performances dans la durée de nos deux axes stratégiques, les...

VETOQUINOL : MISE A DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL (DEU) 2023

Regulatory News: Vetoquinol (Parois:VETO) a déposé le 24 avril 2024 auprès de l’Autorité des marchés financiers (AMF) son Document d’enregistrement universel (DEU) 2023 au format ESEF (Format...

VETOQUINOL: RÉSULTATS ANNUELS 2023

Regulatory News: Vetoquinol (Paris:VETO): Chiffre d’affaires annuel : 529 M€ (stable à changes constants) CA produits Essentiels : 313 M€ (+4,5 % à changes constants) Résultat net part du Groupe...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-3.7-4.45783132538383.478.3135980.71251104DE
4-2.1-2.5798525798581.48577.9184181.19267034DE
12-14.1-15.09635974393.498.477.9252384.5488885DE
26-22.1-21.7948717949101.410677.9225491.43611387DE
52-10.6-11.790878754289.911077.9263095.89637435DE
156-65.7-45.310344827614514976.33001105.9426225DE
26021.737.673611111157.616141.9300097.57008625DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLAAHAmatheon Agri Holding NV
0.02 €
(100.00%)
5k
GNROGeNeuro SA
0.0768 €
(25.49%)
200
BIDSGascogne DS
0.005 €
(25.00%)
150.51k
ALSAFSAFE
0.11 €
(23.73%)
39.98k
ALKKOKKO International SA
0.112 €
(21.21%)
4.13M
ALIMOGroupimo
0.189 €
(-40.94%)
392
MLUMGUmalis Group
1.30 €
(-31.22%)
1.71k
MLNMAMiguet Et Associes
0.075 €
(-24.62%)
1.72k
MLSEQSequa Petroleum NV
0.008 €
(-20.00%)
23k
VACBSPierre & Vacances
0.05 €
(-15.25%)
35.99k
BCPBanco Comercial Portugues SA
0.4446 €
(-0.49%)
69.24M
ALNEVNeovacs
0.0002 €
(0.00%)
41.4M
ALCYBCybergun
0.0001 €
(0.00%)
30.32M
INGAING Groep NV
14.652 €
(-1.16%)
14.06M
ACACredit Agricole SA
13.05 €
(-1.66%)
8.06M

Discussion

View Full Feed
Azart Azart 13 minutes ago
My friend what Scamus is currently doing is absolutely not new. This is exactly how everything was transferred from the previous company to becoming Rannever Health back in 2014 or 15 if I am not mistaken. The back then CEO before Scamus did the exact same thing Scamus is doing with Foxo. Common hol
RNVA
SteveSchiets SteveSchiets 18 minutes ago
There was a lot of resistance not acting up on my belief S7 hasn't play it's final hand. The fact that ACC's are used by our competitors made me do that silly thing. Maybe also because other stocks in my portfolio needs more time, i decided to have one last go (it's never the last). If trillions wi
SEV
knrorrel knrorrel 55 minutes ago
no chance in the quantum hype, $10 could come quickly now, like on Friday with qmco (+171%, only on Friday increased from $3.60 to $11!)

and it's a shame that they couldn't buy more,

but I feel the same way (I also have far too little of $QBTS but unfortunately I don'
QBTS
chen1992 chen1992 1 hour ago
https://youtu.be/PaMsc8z1Ls4?si=u3MwvbGovNMyWXI6


Inverse Cramer at it again! Did it for TELL!!!!
TGLO
silkmaster silkmaster 1 hour ago
It looks like we can only guss what would the pps will look like in a week/month or a year from now .
Mean while lets play what would the PPS look like come 30/11/24 so long as KT will come out and talk to the public by than that is ...

A. 0.09 (around current pps)
B. 0.
KBLB
ZLAZARUS ZLAZARUS 1 hour ago
Ph3 melanoma data for IO102-IO103 remain on track for 1H25 and represents the next key catalyst. At .70 we are trading at cash. With a positive Ph3 melanoma readout we will be trading at $3.00 overnight with a march to $6.00 towards the later half of 2025. In addition, I'm encouraged by the support
IOBT
knrorrel knrorrel 1 hour ago
https://de.tradingview.com/chart/Mq3nUQ7Y/?symbol=NYSE%3AQBTS
QBTS
knrorrel knrorrel 2 hours ago
friday +171% / $11 and $Q_BTS follows on Monday, which is much better than QMCO and still has a lot of potential to trade above $10 ?
all only imho

here: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175432596


QMCO
Whalatane Whalatane 2 hours ago
Yes There will be less of a reaction in the UNCY stock for the reason you mentioned
ARDX is saying they will supply Xphozah free of charge to Medicare patients who lose coverage in Jan ...for the first 2 mths only
Nephrologists are probably already pulling back from starting Medicare
ARDX UNCY
SCAMBUSTERKING SCAMBUSTERKING 2 hours ago
My statements are backed up by the court docs filed by Jake and his lawyer... then even more proven by the actions of Jake.
BCAP
chereb19 chereb19 2 hours ago
An even bigger Whopper of a lie. Can't believe anything you write, there's are too many examples of your lies. Dishonest and incompetent?
RDGL
knrorrel knrorrel 2 hours ago
THE $QBTS TREND https://stockcharts.com/sc3/ui/?s=QBTS
QBTS
weedtrader420 weedtrader420 2 hours ago
☝️🤑☝️📈🚀
SUKUUSD
knrorrel knrorrel 2 hours ago
THE $QBTS TREND https://stockcharts.com/sc3/ui/?s=QBTS
QBTS
fuagf fuagf 2 hours ago
And all should understand subsidies discourage innovation leading to efficiency.
You're right too, we are talking about corporate farming in that respect also.
Ray_137 Ray_137 2 hours ago
That can be true plan 7 contains some parts of plan6. Investors in WAMU signed releases based on plan7.
COOP
Kam8 Kam8 2 hours ago
I am guessing $2+ after approval in UK, not only 27cents. 
NWBO
dstock07734 dstock07734 2 hours ago
George,

It could be none of them.
NWBO
snoopycomic snoopycomic 2 hours ago
Dufus- OS is the measurement.
NWBO
snoopycomic snoopycomic 2 hours ago
OS is the measurement fugue. Get with the program
NWBO
Dallas-Cowboys Dallas-Cowboys 2 hours ago
Natural gas and nuclear (a lot longer timeframe) are the answer to the massive Datacenters that are being constructed for AI. They already consume 100's of megawatts soon to be gigawatts of power. They use the equivalent consumption of neighborhoods and towns. Cranmer is a showman and sometimes Bozo
TGLO

Your Recent History

Delayed Upgrade Clock